Navigation Links
Arena Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Health Care Conference
Date:11/23/2011

tion of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: the timing of regulatory review and approval is uncertain; regulatory agencies may interpret or weigh the importance of data differently and reach different conclusions than Arena or others, request additional information, have additional recommendations or change their guidance or requirements before or after approval; the risk that data and other information related to Arena's research and development programs may not meet safety or efficacy requirements or otherwise be sufficient for regulatory approval; Arena's response to the complete response letter for the lorcaserin new drug application or submission of a marketing authorization application for regulatory approval of lorcaserin may not be submitted when anticipated, if at all; unexpected or unfavorable new data; risks related to commercializing new products; Arena's ability to obtain and defend its patents; the timing, success and cost of Arena's research and development programs; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; Arena's ability to obtain adequate funds; risks related to relying on collaborative agreements; the timing and receipt of payments and fees, if any, from collaborators; and satisfactory resolution of pending and any future litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena'
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 Encision Inc. (OTCQB:ECIA), a medical ... stray electrosurgical burns in minimally invasive surgery, today announced ... fiscal year ended March 31, 2015. The ... a quarterly net loss of $349 thousand, or $(0.03) ... $2.504 million for a net loss of $1.453 million, ...
(Date:5/27/2015)... 2015 Una presentazione speciale durante la settimana ... esperti di MERG valutare i successi ottenuti ... di svariate popolazioni di pazienti affetti dalla patologia. ... Ronnie Fass , MD della Case Western Reserve ... clinici relativi alla terapia Stretta. Un panel di esperti ...
(Date:5/27/2015)... May 27, 2015  Easter Seals is marking ... by launching a national smoking cessation program to ... healthier, tobacco-free lives. Funding for the new program ... CVS Health Foundation. The cessation program highlights the American Lung ... Smoking, which take participants through modules ...
Breaking Medicine Technology:Encision Reports Fourth Quarter And Fiscal Year 2015 Results 2Encision Reports Fourth Quarter And Fiscal Year 2015 Results 3Encision Reports Fourth Quarter And Fiscal Year 2015 Results 4Encision Reports Fourth Quarter And Fiscal Year 2015 Results 5Encision Reports Fourth Quarter And Fiscal Year 2015 Results 6Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 2Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 3Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 4CVS Health Foundation, Easter Seals Team Up To Mark World No Tobacco Day With Launch Of New Smoking Cessation Program For Veterans, People With Disabilities 2CVS Health Foundation, Easter Seals Team Up To Mark World No Tobacco Day With Launch Of New Smoking Cessation Program For Veterans, People With Disabilities 3
... today that it has completed a remediation action for ... corrosion.  This class I recall notice is being issued ... Administration (FDA).  No further action is necessary. ... consequences or death associated with the type of malfunction ...
... Food and Drug Administration is urging consumers to carefully ... to avoid giving the wrong dose to their infants. ... cause serious side effects and, possibly, death. ... especially concerned about parents and caregivers administering the proper ...
Cached Medicine Technology:Ikaria® Issues Notice of Completed Remediation for INOMAX® DS Drug-delivery System 2Ikaria® Issues Notice of Completed Remediation for INOMAX® DS Drug-delivery System 3FDA CONSUMER HEALTH INFORMATION - Know Concentration Before Giving Acetaminophen to Infants 2
(Date:5/27/2015)... (PRWEB) May 27, 2015 This year, ... health awareness campaign and encouraging those affected to seek assistance ... Mental Health (NAMI), one in five children, ages 13 ... illness. Additionally, 50% of all cases of mental illness within ... suggesting, it is essential to seek help before reaching a ...
(Date:5/27/2015)... One of America's most cherished actors, James Earl ... that takes a look at the topic of atrial ... abnormal heart rhythm. Those who suffer from atrial fibrillation ... too quickly. , This new segment will take a ... to inform viewers about possible signs that commonly indicate ...
(Date:5/27/2015)... Long Island, New York (PRWEB) May 27, 2015 ... Wellness Day Spa will now be offering Eco-fin ... 2015. The Eco-fin treatment is a paraffin wax alternative. ... is made with 100% natural plant-based emollients and pure ... are used. , "We have used Eco-fin treatments for ...
(Date:5/27/2015)... The Advanced Fertility Center of Chicago announces that their ... better serve the needs of couples in Chicagoland. The ... Northwest side of the city at 4920 North Central Ave., ... the Chicago office at (773) 794–1818. This is the ... The other 2 offices are in Gurnee and Crystal ...
(Date:5/26/2015)... May 27, 2015 Local dentist Abid ... more restful night’s sleep. Dr. Paghdiwala of Pearl Dental ... Medicine (AADSM) member. AADSM is the leading national organization ... with oral appliance therapy, an effective alternative treatment to ... , “Sleeping with a CPAP machine, which ...
Breaking Medicine News(10 mins):Health News:The Glenholme School Observes Mental Health Awareness Month 2Health News:The Glenholme School Observes Mental Health Awareness Month 3Health News:Long Island's Massage and Spa Of Commack Announces A Change To Their Spa Party Menu Of Services 2Health News:Long Island's Massage and Spa Of Commack Announces A Change To Their Spa Party Menu Of Services 3Health News:The Advanced Fertility Center of Chicago Opens a New Fertility Office Location in Chicago 2Health News:Philadelphia sleep apnea dentist now offers oral appliances to treat snoring 2
... value has been attached to the high cost of pain ... a massive annual cost of $34.3 billion -- nearly $11,000 ... pain. The price tag of pain includes both financial ... study The High Price of Pain: The Economic Impact of ...
... 90% of people miss out on critical early treatment period, ... call them transient ischemic attacks, but they,re more commonly known ... be deadly. , What,s worse, many people who suffer such ... people who experienced symptoms of a transient ischemic attack (TIA) ...
... Holdings, Inc. ("IHHI") (OTC Bulliten Board: IHCH), the ... its financial,results for the second quarter ended September ... reported consolidated net operating revenues of $95.4 million ... increase of $10.1 million, or,11.8%, from the comparable ...
... Drug Costs for America,s Seniors, WASHINGTON, Nov. ... of Inspector General (OIG) finding that in Medicare ... the time when generic,substitutes were available and that ... that proven pharmacy benefit manager (PBM) tools are,driving ...
... - ZYRTEC(R) and ZYRTEC-D(R) 12 HOUR(R) to be Available in Stores ... ... FT. WASHINGTON, Pa., Nov. 16 McNeil Consumer,Healthcare, a division of ... and Drug Administration (FDA) for the,allergy treatment ZYRTEC(R) (cetirizine HCl) to ...
... Nov. 16 The National Football,League Alliance Partnership ... heart health screenings for former NFL players. ... Medical Center.,Partnering with Dr. Jeffrey Boone, founder of ... medical experts and a 64-slice CT scanner.,More than ...
Cached Medicine News:Health News:First study of Australia's high cost of pain reveals $34 billion price tag 2Health News:Mini Strokes: Major Health Threats 2Health News:Mini Strokes: Major Health Threats 3Health News:IHHI Announces Second Quarter Earnings 2Health News:IHHI Announces Second Quarter Earnings 3Health News:New OIG Report Confirms Part D Plans Are Driving Generic Utilization 2Health News:FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription 2Health News:FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription 3Health News:FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription 4Health News:Broward Health and ProHeart MD Kick Off NFL Alumni Health Program 2
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
0.12 mm, 1 x 2 teeth set at 45 degrees with 5 mm tying platform. Serrated handle with polished finish....
Serrated handle with 7 mm tying platform and polished finish. Teeth: 0.25 mm, 2 x 2 set at 45 degrees....
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 45 degrees....
Medicine Products: